Charlotte's Web Holdings (CWBHF) Shares Outstanding (Weighted Average) (2020 - 2026)
Charlotte's Web Holdings (CWBHF) reported Shares Outstanding (Weighted Average) of $159.7 million for Q1 2026, up 1.05% year-over-year from $158.0 million in Q1 2025, and up 0.55% quarter-over-quarter from $158.8 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $159.7 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $159.7 million, up 1.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $159.7 million (up 1.05% YoY), and the FY2025 annual result was $158.8 million, up 0.78% from the prior year.
- Shares Outstanding (Weighted Average) improved to $159.7 million in Q1 2026 per CWBHF's latest filing, from $158.8 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $159.7 million in Q1 2026 and troughed at $145.0 million in Q1 2022.
- A 5-year average of $153.8 million and a median of $156.0 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) grew 5.43% in 2023, then increased 0.78% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $146.6 million in 2022, then rose by 4.3% to $152.9 million in 2023, then grew by 3.02% to $157.6 million in 2024, then grew by 0.78% to $158.8 million in 2025, then climbed by 0.55% to $159.7 million in 2026.
- Business Quant data shows CWBHF's Shares Outstanding (Weighted Average) at $159.7 million in Q1 2026, $158.8 million in Q4 2025, and $159.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | 159.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.67 Mn |
| Dec 31, 2025 | 158.79 Mn |
| Sep 30, 2025 | 159.11 Mn |
| Jun 30, 2025 | 158.61 Mn |
| Mar 31, 2025 | 158.01 Mn |
| Dec 31, 2024 | 157.56 Mn |
| Sep 30, 2024 | 157.50 Mn |
| Jun 30, 2024 | 156.63 Mn |
| Mar 31, 2024 | 156.04 Mn |
| Dec 31, 2023 | 152.94 Mn |
| Sep 30, 2023 | 153.09 Mn |
| Jun 30, 2023 | 152.48 Mn |
| Mar 31, 2023 | 152.31 Mn |
| Dec 31, 2022 | 146.63 Mn |
| Sep 30, 2022 | 145.20 Mn |
| Jun 30, 2022 | 145.17 Mn |
| Mar 31, 2022 | 144.99 Mn |
| Dec 31, 2021 | 140.77 Mn |
| Sep 30, 2021 | 140.05 Mn |
| Jun 30, 2021 | 139.94 Mn |